Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT02873208
Eligibility Criteria:
Inclusion Criteria:
* Agrees to use an acceptable method of contraception for the duration of the study
* Subject has completed the 24-week treatment period in the antecedent study, ALK3831-A303, within 7 days
* Additional criteria may apply
Exclusion Criteria:
* Subject is currently taking medications that are contraindicated with olanzapine use or exhibit drug-interaction potential with olanzapine
* Subject has a positive test for drugs of abuse at study entry
* Subject is pregnant, planning to become pregnant, or breastfeeding during the study
* Additional criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT02873208
Study Brief:
Protocol Section:
NCT02873208